Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-29

Clinical Trial Update: Comparison of ACT Between Hemochron Jr and ACT Plus [NA]

View source ↗

Summary

This completed clinical trial compares activated clotting time measurements between Hemochron Jr and ACT Plus devices in patients with cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hallym University Medical Center | Conditions: Cardiac Disease | NA | Status: COMPLETED